Sr. FDA official calls Uniqure's Huntington's disease treatment a failure
05/03/2026 18:10
March 5 (Reuters) - A senior FDA official called Uniqure's UQ1.F experimental Huntington's disease treatment a "failed product" in a conference call with media members on Thursday, casting further doubt on the prospects of its experimental gene therapy. (Reporting by Mrinalika Roy in Bengaluru) ((mrinalika.roy@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal